BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2995998)

  • 1. The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.
    Hoerner CR; Chen VJ; Fan AC
    Kidney Cancer; 2019 Feb; 3(1):15-29. PubMed ID: 30854496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and metabolic hallmarks of clear cell renal cell carcinoma.
    Sanchez DJ; Simon MC
    Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):23-31. PubMed ID: 29959988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma.
    Maroto P; Esteban E; Parra EF; Mendez-Vidal MJ; Domenech M; Pérez-Valderrama B; Calderero V; Pérez-Gracia JL; Grande E; Algaba F
    Onco Targets Ther; 2017; 10():4635-4643. PubMed ID: 29033582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence.
    Atta IS; AlQahtani FN
    Case Rep Med; 2016; 2016():2928084. PubMed ID: 27087812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.
    Shroff EH; Eberlin LS; Dang VM; Gouw AM; Gabay M; Adam SJ; Bellovin DI; Tran PT; Philbrick WM; Garcia-Ocana A; Casey SC; Li Y; Dang CV; Zare RN; Felsher DW
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6539-44. PubMed ID: 25964345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell Carcinoma.
    Tang SW; Lin JY
    J Oncol; 2012; 2012():680796. PubMed ID: 22545051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.
    Boer JM; Huber WK; Sültmann H; Wilmer F; von Heydebreck A; Haas S; Korn B; Gunawan B; Vente A; Füzesi L; Vingron M; Poustka A
    Genome Res; 2001 Nov; 11(11):1861-70. PubMed ID: 11691851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
    Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
    Am J Pathol; 1999 Apr; 154(4):981-6. PubMed ID: 10233835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.
    Gemmill RM; West JD; Boldog F; Tanaka N; Robinson LJ; Smith DI; Li F; Drabkin HA
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9572-7. PubMed ID: 9689122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.
    Waldmann V; Rabes HM
    J Cancer Res Clin Oncol; 1996; 122(4):207-13. PubMed ID: 8601572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the interleukin 5 receptor gene to human chromosome 3 p25-p26 and to mouse chromosome 6 close to the Raf-1 locus with polymorphic tandem repeat sequences.
    Jacob CO; Mykytyn K; Varcony T; Drabkin HA
    Mamm Genome; 1993; 4(8):435-9. PubMed ID: 8104057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint.
    Boldog FL; Gemmill RM; Wilke CM; Glover TW; Nilsson AS; Chandrasekharappa SC; Brown RS; Li FP; Drabkin HA
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8509-13. PubMed ID: 7690964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of a third purine biosynthetic gene (glycinamide ribonucleotide transformylase) to human chromosome 21.
    Hards RG; Benkovic SJ; Van Keuren ML; Graw SL; Drabkin HA; Patterson D
    Am J Hum Genet; 1986 Aug; 39(2):179-85. PubMed ID: 3529945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cancer and cellular oncogenes.
    Nishimura S; Sekiya T
    Biochem J; 1987 Apr; 243(2):313-27. PubMed ID: 3307760
    [No Abstract]   [Full Text] [Related]  

  • 15. Oncogenes and urological malignancies: implications for the future.
    Schalken JA; van den Ouweland AM; Debruijne FM; Karthaus HF; Van de Ven WJ
    Urol Res; 1988; 16(5):333-9. PubMed ID: 3059653
    [No Abstract]   [Full Text] [Related]  

  • 16. The complete coding sequence of the human A-raf-1 oncogene and transforming activity of a human A-raf carrying retrovirus.
    Beck TW; Huleihel M; Gunnell M; Bonner TI; Rapp UR
    Nucleic Acids Res; 1987 Jan; 15(2):595-609. PubMed ID: 3029685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional localization of chromosome 3-specific DNA fragments by using a hybrid cell deletion mapping panel.
    Gerber MJ; Drabkin HA; Firnhaber C; Miller YE; Scoggin CH; Smith DI
    Am J Hum Genet; 1988 Oct; 43(4):442-51. PubMed ID: 2902784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer.
    Drabkin H; Kao FT; Hartz J; Hart I; Gazdar A; Weinberger C; Evans R; Gerber M
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9258-62. PubMed ID: 2848257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of c-myc in the hereditary renal cell carcinoma associated with a t(3;8)(p14.2;q24.13) chromosomal translocation.
    Drabkin HA; Bradley C; Hart I; Bleskan J; Li FP; Patterson D
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6980-4. PubMed ID: 2995998
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.